Greg Fariss

Greg Fariss currently serves as the Director of Manufacturing at ECM Therapeutics, Inc., a position held since 2024. Prior to this role, Greg was the Vice President of Process Technology at BioSpectra, Inc. from 2023 to 2024. Between 2017 and 2023, Greg worked at Viatris as the Director of Quality Engineering/Validations. From 2002 to 2017, Greg held the position of Director of Process Development/Technical Operations at Par Pharmaceutical. Greg Fariss holds a Bachelor of Science (B.S.) in Chemistry from East Tennessee State University.